MDT

98.74

-1.06%↓

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

Home・Aktien・Vivani Medical

Vivani Medical

Geschlossen

1.27

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

1.24

Max

1.31

Schlüsselkennzahlen
By Trading Economics
Angestellte	37

Empfehlungen
By TipRanks
Empfehlungen	Buy
12-Monats-Prognose	+210.08% upside

Dividenden
By Dow Jones
Nächstes Ergebnis	30. März 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-21M 83M
Vorheriger Eröffnungskurs	1.27
Vorheriger Schlusskurs	1.27

Vivani Medical Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

8. Jan. 2026, 23:08 UTC

Akquisitionen, Fusionen, Übernahmen

Rio Tinto, Glencore in Talks to Form World's Biggest Miner -- 3rd Update

8. Jan. 2026, 21:39 UTC

Akquisitionen, Fusionen, Übernahmen

Glencore, Rio Tinto Restart Merger Talks -- 2nd Update

8. Jan. 2026, 20:54 UTC

Akquisitionen, Fusionen, Übernahmen

Glencore, Rio Tinto Restart Merger Talks -- Update

8. Jan. 2026, 20:44 UTC

Akquisitionen, Fusionen, Übernahmen

Glencore, Rio Tinto Restart Merger Talks

8. Jan. 2026, 17:05 UTC

Akquisitionen, Fusionen, Übernahmen

Chinese Anta Sports Products Offers to Buy Pinault Family's Stake in Puma, Reuters Says, Citing Unnamed Sources

8. Jan. 2026, 16:43 UTC

Wichtige Markttreiber

Babcock & Wilcox Shares Rise on Siemens Deal for Data Center Project

8. Jan. 2026, 23:44 UTC

Market Talk

Nikkei May Rise on Weaker Yen -- Market Talk

8. Jan. 2026, 23:37 UTC

Market Talk

Gold Steady, Underpinned by Geopolitical Risks -- Market Talk

8. Jan. 2026, 22:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

8. Jan. 2026, 22:42 UTC

Market Talk

RBA Still Battling a Troubling Inflation Outlook, Says TD -- Market Talk

8. Jan. 2026, 22:30 UTC

Akquisitionen, Fusionen, Übernahmen

Glencore, Rio Tinto Confirm Early Merger Talks -- Barrons.com

8. Jan. 2026, 21:53 UTC

Ergebnisse

These Stocks Moved the Most Today: Lockheed, Northrop, Alphabet, Applied Digital, Bloom Energy, Neogen, and More -- Barrons.com

8. Jan. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

8. Jan. 2026, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

8. Jan. 2026, 21:10 UTC

Akquisitionen, Fusionen, Übernahmen

Rio Tinto Says Current Expectation That Any Deal Would Involve Buying Glencore Via Scheme of Arrangement

8. Jan. 2026, 21:09 UTC

Market Talk

Oil Rises As Trump Said to Back Russia Sanctions Bill -- Market Talk

8. Jan. 2026, 21:09 UTC

Akquisitionen, Fusionen, Übernahmen

Rio Tinto Confirms in Talks With Glencore Over Possible Merger

8. Jan. 2026, 20:21 UTC

Market Talk

U.S. Natural Gas Futures Down Despite Inventory Draw -- Market Talk

8. Jan. 2026, 19:44 UTC

Market Talk

Gold's Shine Masks Deep Drops in Canada Steel, Aluminum Exports -- Market Talk

8. Jan. 2026, 18:50 UTC

Market Talk

Mexico's Industrial Production Seen Lower in November -- Market Talk

8. Jan. 2026, 17:48 UTC

Ergebnisse

These Stocks Are Moving the Most Today: Lockheed, Northrop, Alphabet, Applied Digital, Bloom Energy, Neogen, and More -- Barrons.com

8. Jan. 2026, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

8. Jan. 2026, 17:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

8. Jan. 2026, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

8. Jan. 2026, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

8. Jan. 2026, 16:45 UTC

Market Talk

Goldman Lifts 1H LME Copper Forecast -- Market Talk

8. Jan. 2026, 16:03 UTC

Market Talk

Global Equities Roundup: Market Talk

8. Jan. 2026, 16:03 UTC

Market Talk

Currency Markets Could Be Underpricing Medium-Term Risks -- Market Talk

8. Jan. 2026, 16:02 UTC

Market Talk

U.S. Natural Gas Inventories Fall As Expected -- Market Talk

8. Jan. 2026, 15:23 UTC

Akquisitionen, Fusionen, Übernahmen

Paramount Defends Its Hostile Bid for Warner -- Update

Peer-Vergleich

Kursveränderung

Vivani Medical Prognose

Kursziel

By TipRanks

210.08% Vorteil

12-Monats-Prognose

Durchschnitt 4 USD 210.08%

Hoch 4 USD

Tief 4 USD

Basierend auf 2 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Vivani Medical – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

2 ratings

Buy

Halten

Sell

Basierend auf 2 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Vivani Medical – Dist abgegeben haben.

Finanzen

Über Vivani Medical

Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California.